What is the address of SOCIETE MEDICALE BUONOMO?

The registered office of SOCIETE MEDICALE BUONOMO is located at Rue du Marais(ROI) 13, 7387 Honnelles.

Is SOCIETE MEDICALE BUONOMO still active?

Yes. According to the CBE (28 September 2026) SOCIETE MEDICALE BUONOMO is active, legal situation “Normale toestand”, started on 6 January 2003.

Is SOCIETE MEDICALE BUONOMO registered on Peppol?

Yes, SOCIETE MEDICALE BUONOMO is registered on the Peppol network with ID 0208:0479236616.

What is the enterprise number of SOCIETE MEDICALE BUONOMO?

The enterprise number of SOCIETE MEDICALE BUONOMO is BE0479236616.

When was SOCIETE MEDICALE BUONOMO founded?

SOCIETE MEDICALE BUONOMO was founded on 6 January 2003.

Who are the directors of SOCIETE MEDICALE BUONOMO?

According to the 2025 annual accounts, the directors of SOCIETE MEDICALE BUONOMO are: SALVATORE BUONOMO, ANTONINO BUONOMO.

Is SOCIETE MEDICALE BUONOMO a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 6 January 2003; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did SOCIETE MEDICALE BUONOMO make in 2025?

SOCIETE MEDICALE BUONOMO posted a profit after taxes of € 28,956 in financial year 2025.

What is the revenue of SOCIETE MEDICALE BUONOMO?

As a small company, SOCIETE MEDICALE BUONOMO is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 160,741.

SOCIETE MEDICALE BUONOMO (Private Limited) - Honnelles

Dossier SOCIETE MEDICALE BUONOMO, printed on 28 September 2026 from databakkes.be/en/0479236616/societe-medicale-buonomo. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

SOCIETE MEDICALE BUONOMO from Honnelles, company number BE0479236616, closed financial year 2025 with a result of € 28,956 after tax. For that financial year SOCIETE MEDICALE BUONOMO recorded a gross margin of € 160,741 and equity of € 272,910. Compared with financial year 2024, the result moved from € 53,705 to € 28,956. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Healthy

€ 272,910

▼ 16% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 28,956

▼ 46% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 80,123

▲ 33% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 80,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 87,627

▼ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 4 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 351,452

▼ 11% vs 2024

€ 78,660 is repaid this year. At this pace the long-term loan is gone in ≈ 4 years.

Owed to suppliers

€ 13,536

▲ 279% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 30,675

▼ 12% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 64,045 Gross margin 2022: € 64,045 First fiscal year in the series	€ 81,855 Gross margin 2023: € 81,855 ▲ 28% vs 2022 (€ 64,045) Favourable step	€ 154,537 Gross margin 2024: € 154,537 ▲ 89% vs 2023 (€ 81,855) Favourable step	€ 160,741 Gross margin 2025: € 160,741 ▲ 4% vs 2024 (€ 154,537) Favourable step	▲ 4%
Profit after taxes	€ -11,856 Profit after taxes 2022: € -11,856 First fiscal year in the series	€ 39,258 Profit after taxes 2023: € 39,258 ▲ € 51,114 vs 2022 (€ -11,856) Favourable step	€ 53,705 Profit after taxes 2024: € 53,705 ▲ 37% vs 2023 (€ 39,258) Favourable step	€ 28,956 Profit after taxes 2025: € 28,956 ▼ 46% vs 2024 (€ 53,705) Unfavourable step	▼ 46%
Equity	€ 405,991 Equity 2022: € 405,991 First fiscal year in the series	€ 370,250 Equity 2023: € 370,250 ▼ 9% vs 2022 (€ 405,991) Unfavourable step	€ 323,954 Equity 2024: € 323,954 ▼ 13% vs 2023 (€ 370,250) Unfavourable step	€ 272,910 Equity 2025: € 272,910 ▼ 16% vs 2024 (€ 323,954) Unfavourable step	▼ 16%
Total debts	€ 486,409 Total debts 2022: € 486,409 First fiscal year in the series	€ 393,704 Total debts 2023: € 393,704 ▼ 19% vs 2022 (€ 486,409) Favourable step	€ 435,497 Total debts 2024: € 435,497 ▲ 11% vs 2023 (€ 393,704) Unfavourable step	€ 396,911 Total debts 2025: € 396,911 ▼ 9% vs 2024 (€ 435,497) Favourable step	▼ 9%
Cash	€ 85,838 Cash 2022: € 85,838 First fiscal year in the series	€ 43,279 Cash 2023: € 43,279 ▼ 50% vs 2022 (€ 85,838) Unfavourable step	€ 60,109 Cash 2024: € 60,109 ▲ 39% vs 2023 (€ 43,279) Favourable step	€ 80,123 Cash 2025: € 80,123 ▲ 33% vs 2024 (€ 60,109) Favourable step	▲ 33%
Land & buildings	€ 454,929 Land & buildings 2022: € 454,929 First fiscal year in the series	€ 435,828 Land & buildings 2023: € 435,828 ▼ 4% vs 2022 (€ 454,929) Unchanged	€ 410,348 Land & buildings 2024: € 410,348 ▼ 6% vs 2023 (€ 435,828) Unchanged	€ 388,180 Land & buildings 2025: € 388,180 ▼ 5% vs 2024 (€ 410,348) Unchanged	▼ 5%
Retained profit	€ 399,791 Retained profit 2022: € 399,791 First fiscal year in the series	€ 364,050 Retained profit 2023: € 364,050 ▼ 9% vs 2022 (€ 399,791) Unfavourable step	€ 317,754 Retained profit 2024: € 317,754 ▼ 13% vs 2023 (€ 364,050) Unfavourable step	€ 266,710 Retained profit 2025: € 266,710 ▼ 16% vs 2024 (€ 317,754) Unfavourable step	▼ 16%
Dividend	€ 60,000 Dividend 2022: € 60,000 First fiscal year in the series	€ 75,000 Dividend 2023: € 75,000 ▲ 25% vs 2022 (€ 60,000) Unchanged	€ 100,000 Dividend 2024: € 100,000 ▲ 33% vs 2023 (€ 75,000) Unchanged	€ 80,000 Dividend 2025: € 80,000 ▼ 20% vs 2024 (€ 100,000) Unchanged	▼ 20%
Bank debt	€ 355,425 Bank debt 2022: € 355,425 First fiscal year in the series	€ 351,649 Bank debt 2023: € 351,649 ▼ 1% vs 2022 (€ 355,425) Favourable step	€ 394,465 Bank debt 2024: € 394,465 ▲ 12% vs 2023 (€ 351,649) Unfavourable step	€ 351,452 Bank debt 2025: € 351,452 ▼ 11% vs 2024 (€ 394,465) Favourable step	▼ 11%
Balance sheet total	€ 892,401 Balance sheet total 2022: € 892,401 First fiscal year in the series	€ 763,954 Balance sheet total 2023: € 763,954 ▼ 14% vs 2022 (€ 892,401) Unchanged	€ 759,451 Balance sheet total 2024: € 759,451 ▼ 1% vs 2023 (€ 763,954) Unchanged	€ 669,821 Balance sheet total 2025: € 669,821 ▼ 12% vs 2024 (€ 759,451) Unchanged	▼ 12%

Key figures of SOCIETE MEDICALE BUONOMO, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to SOCIETE MEDICALE BUONOMO?

What happened at SOCIETE MEDICALE BUONOMO in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 28,956 (▼ 46% vs 2024). filed late Source: NBB ↗
Jan 6, 2003 Start of the company according to the CBE. KBO

In short

From € 11,856 loss in 2022 to € 28,956 profit in 2025.

Paid € 93,604 in corporate taxes since 2022.

Best year ever: 2024, with € 53,705 profit.

Paid out € 315,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at SOCIETE MEDICALE BUONOMO? We notify you, reason included.

Follow SOCIETE MEDICALE BUONOMO

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

SALVATORE BUONOMO ANTONINO BUONOMO

SOCIETE MEDICALE BUONOMO

Behind SOCIETE MEDICALE BUONOMO are SALVATORE BUONOMO and ANTONINO BUONOMO.

See the full network in the app

Directors

According to the 2025 annual accounts

SALVATORE BUONOMO

Director

ANTONINO BUONOMO

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Marais(ROI) 13

7387 Honnelles

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0479.236.616
VAT number: BE 0479.236.616
Registered office: Rue du Marais(ROI) 13, 7387 Honnelles
Names & denominations: SOCIETE MEDICALE BUONOMO
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 6 January 2003
Peppol: Active · Active since 10 Jan 2026

View on CBE Public ↗ Annual accounts (NBB) ↗